TABLE 4.
Clinical description of people with HIV who died during admission.
Patient | Age (years) | Gender | Comorbidities | CD4 count (cells/µL) | HIV-1 viral load (IU/mL) | ROX score† |
---|---|---|---|---|---|---|
1 | 60–79 | Male | Hypertension | 375 | LDL | 1.9 |
2 | < 40 | Female | Overweight | 36 | LDL | 3.0 |
3 | < 40 | Female | Active TB‡ | 106 | - | 15.6 |
4 | 40–59 | Male | Diabetes B cell lymphoblastic leukaemia |
387 | LDL | 2.7 |
5 | 40–59 | Male | CKD stage 5 | - | - | - |
6 | 40–59 | Female | Suspected SLE§ | 608 | LDL | 12.5 |
7 | 60–79 | Male | CKD stage 5 Epilepsy |
159 | - | 5.7 |
8 | < 40 | Male | Chronic HBV HBV viral load = 64 113 IU/mL B cell lymphoma Active TB on treatment at admission |
20 | 3310 | 10.2 |
9 | 60–79 | Female | Hypertension Diabetes Obesity CKD stage 3 |
612 | - | 3.2 |
10 | 40–59 | Female | Disseminated CMV CMV viral load = 27 000 IU/mL Cavitating pneumonia |
44 | 1.36 × 106 | 20.6 |
11 | 40–59 | Male | Hypertension Diabetes |
577 | LDL | 8.3 |
12 | 40–59 | Female | Hypertension Diabetes Previous TB |
429 | LDL | - |
ROX, respiratory oxygenation score; CKD, chronic kidney disease; HBV, Hepatitis B virus; CMV, Cytomegalovirus; LDL, lower than detectable level; TB, tuberculosis; SLE, systemic lupus erythematosus.
, ROX score at admission; ‡, TB treatment started on empirical grounds; §, Anti-nuclear antibody positive, with bicytopenia, rash and joint pain – admitted for haemoptysis and developed nosocomial SARS-CoV-2 infection.